Skip to Main Content

Paper Details

MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer.
Cell Rep
3
2023
AR, Advanced prostate cancers, DRP1, MYC, androgen, androgen receptor, complex I, prostate cancer, prostate tumor, prostate tumor cells, tumors
Androgens, Cell Line, Tumor, Humans, Male, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Proto-Oncogene Proteins c-myc, Receptors, Androgen, Signal Transduction
Author NameAffiliation
Preston D CrowellUniversity of California los angeles
Jenna M GiafaglioneUniversity of California los angeles
Anthony E JonesUniversity of California los angeles
Nicholas M NunleyUniversity of California los angeles
Takao HashimotoUniversity of California los angeles
Amelie M L DelcourtUniversity of California los angeles
Anton PetcherskiDavid Geffen School of Medicine, University of California los angeles
Raag AgrawalJonsson Comprehensive Cancer Center, University of California, David Geffen School of Medicine los angeles
Matthew J BernardUniversity of California los angeles
Johnny A DiazUniversity of California los angeles
Kylie Y HeeringUniversity of California los angeles
Rong Rong HuangUniversity of California los angeles
Jin-Yih LowFred Hutchinson Cancer Research Center
Nedas MatulionisDavid Geffen School of Medicine, University of California los angeles
Nora M NavoneMD Anderson Cancer Center
Huihui YeUniversity of California los angeles
Amina ZoubeidiUniversity of British Columbia
Heather R ChristofkJonsson Comprehensive Cancer Center, University of California, David Geffen School of Medicine, USA Eli and Edythe Broad Stem Cell Research Center los angeles
Matthew B RettigDavid Geffen School of Medicine, University of California los angeles
Robert E ReiterDavid Geffen School of Medicine, University of California los angeles
Michael C HaffnerDivisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, University of Washington
Paul C BoutrosJonsson Comprehensive Cancer Center, University of California, David Geffen School of Medicine, USA Institute for Precision Health los angeles
Orian S ShirihaiUniversity of California, David Geffen School of Medicine, Ben Gurion University of The Negev
Ajit S DivakaruniUniversity of California los angeles
Andrew S GoldsteinUniversity of California, USA Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, USA Eli and Edythe Broad Stem Cell Research Center, USA Molecular Biology Institute los angeles
  • 1 - 25

Datasets